Biological Studies
- PTS134 HCV-NAT - 2nd Quarter 2012;
- PTS135 B19-NAT - 2nd Quarter 2012;
- PTS136 Factor IX - Potency - 3rd Quarter 2012;;
- PTS137 MMR vaccine - potency; either all components or single component- 4th Quarter 2012;
Physico-Chemical Studies
- PTS129 Loss on drying (2.2.32 method d) - End Feb. 2012;
- PTS130 Microbiological assay of antibiotics (2.7.2, Method A: Diffusion) - MidApril 2012;
- PTS131 UV-Vis absorption spectrophotometry (2.2.25); End June 2012;
- PTS132 Thin-layer chromatography (2.2.27) - End Sept. 2012;
- PTS133 Dissolution test (2.9.3, paddle apparatus, UV-Vis absorption spectrophotometry) - End Nov. 2012.
© European Directorate for the Quality of Medicines & HealthCare